Centessa Pharmaceuticals plc ADR’s filing revealed that its General Counsel HUSSAIN IQBAL J unloaded Company’s shares for reported $0.1 million on Aug 15 ’25. In the deal valued at $17.23 per share,6,000 shares were sold. As a result of this transaction, HUSSAIN IQBAL J now holds 105,386 shares worth roughly $1.77 million.
Then, HUSSAIN IQBAL J bought 6,000 shares, generating $103,380 in total proceeds.
Before that, Accardi Mario Alberto sold 8,322 shares. Centessa Pharmaceuticals plc ADR shares valued at $126,751 were divested by the President, Orexin Program at a price of $15.23 per share. As a result of the transaction, Accardi Mario Alberto now holds 208,163 shares, worth roughly $3.5 million.
Truist initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published on July 21, 2025; the price target was $30. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Chardan Capital Markets began covering CNTA with “Buy” recommendation on May 08, 2025. Piper Sandler started covering the stock on March 31, 2025. It rated CNTA as “an Overweight”.
Price Performance Review of CNTA
On Tuesday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock fall -1.24% to $16.79. Over the last five days, the stock has lost -3.17%. Centessa Pharmaceuticals plc ADR shares have risen nearly 37.62% since the year began. Nevertheless, the stocks have risen 0.24% over the past one year. While a 52-week high of $19.09 was reached on 02/07/25, a 52-week low of $9.60 was recorded on 04/09/25.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 16.33, which if violated will result in even more drops to 15.86. On the upside, there is a resistance level at 17.34. A further resistance level may holdings at 17.89.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-08-15, growing by 0.97 million shares to a total of 4.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 3.67 million shares. There was a rise of 20.89%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 07, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.
